Both in Diagnostics
Neogen vs Intellia Therapeutics
Over the past year NEOG returned +91.6% and NTLA returned −1.2%; their daily moves had a correlation of 0.13.
NEOG +91.6% NTLA −1.2%Growth of $1, one year, split-adjusted
| Metric | NEOG | NTLA |
|---|---|---|
| Price | $11.82 | $12.47 |
| Market cap | $2.58B | $1.75B |
| Today | −3.59% | −5.74% |
| 1 month | −3.4% | +2.9% |
| 6 months | +24.0% | −6.0% |
| Year to date | +69.1% | +38.7% |
| 1 year | +89.7% | −5.0% |
| Revenue growth (YoY) | +6.5% | −46.2% |
| Gross margin | 47.4% | 100.0% |
| Net margin | −5.3% | −1392.3% |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | 29.4× |
| Net cash | -$605.6M | $437.8M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 62.1% |
| Short % of float | 5.5% | 38.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).